Autocrine and paracrine effects of peptides on human pituitary cells.
In contrast to normal human pituitaries, GH-secreting adenomas cannot process in vivo ProSRIH whereas they do it in vitro. The existence of an endogenous factor able to inhibit ProSRIH processing in vivo was postulated and such a role was analyzed for GHRH. Results showed that when GH adenomas are incubated in vitro with GHRH 10(-8) M, their ProSRIH contents are decreased, percent inhibition being negatively correlated to the amount of endogenously released GHRH. When incubation is performed in the presence of GHRH antibody in order to block the effect of endogenous GHRH, Pro-SRIH content is increased. The same effects are observed on SRIH release: inhibition by GHRH, stimulation by GHRH antibody. Normal rabbit serum had no effect. It may therefore be concluded that the absence of ProSRIH maturation observed in adenomas in vivo may be the consequence of the GHRH release that is known to be higher from GH adenomas than from normal pituitaries.
INSERM U223, Paris, France.
D
D
Joubert
B
B
Mouhieddine
C
C
Benlot
L
L
Levy
F
F
Peillon
D000236:Adenoma / Q000378:metabolism*; D000328:Adult; D000368:Aged; D000906:Antibodies; D013006:Growth Hormone / Q000378:metabolism*; D013007:Growth Hormone-Releasing Hormone / Q000276:immunology / Q000494:pharmacology*; D006801:Humans; D008875:Middle Aged; D010902:Pituitary Gland / Q000378:metabolism*; D010911:Pituitary Neoplasms / Q000378:metabolism*; D011498:Protein Precursors / Q000378:metabolism; D013004:Somatostatin / Q000378:metabolism
D000906:Antibodies; D011498:Protein Precursors; D013004:Somatostatin; C028456:prosomatostatin; D013006:Growth Hormone; D013007:Growth Hormone-Releasing Hormone